期刊文献+

Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy 被引量:1

Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy
下载PDF
导出
摘要 AIM: To investigate the role of the duodenum in the regulation of plasma ghrelin levels and body mass index (BMI), and the correlation between them after subtotal gastrectomy. METHODS: Forty-two patients with T0-1N0-1M0 gastric cancer were divided into two groups after gastrectomy according to digestive reconstruction pattern, Billroth Ⅰ group (n = 23) and Billroth Ⅱ group (n = 19). Ghrelin levels were determined with radioimmunoassay (RIA) before and on d 1, 7, 30 and 360 after gastrectomy, and BMI was also measured. RESULTS: The two groups had identical postoperative trends in ghrelin alterations during the early stage, both decreasing sharply to a nadir on d 1 (36.7% vs 35.7%), then markedly increasing on d 7 (51.0% vs 51.1%). On d 30, ghrelin levels in the Billroth Ⅰ group were slightly higher than those in the Billroth Ⅱ group. However, those of the Billroth Ⅰ group recovered to 93.6% on d 360, which approached, although lower than, the preoperative levels, and no statistically significant difference was observed. Those of the Billroth Ⅱ group recovered to only 81.6% and manifested significant discrepancy with preoperative levels (P = 0.033). Compared with preoperative levels, ghrelin levels of the two groups decreased by 6.9% and 18.4% and BMI fellby 3.3% and 6.4%, respectively. The linear regression correlations were revealed in both groups between decrease of ghrelin level and BMI (R12 = 0.297, P = 0.007; R22 = 0.559, P < 0.001).CONCLUSION: Anatomically and physiologically, the duodenum compensatively promotes ghrelin recovery and accordingly enhances BMI after gastrectomy. Regarding patients with insufficient ghrelin secretion, ghrelin is positively associated with BMI. AIM: To investigate the role of the duodenum in the regulation of plasma ghrelin levels and body mass index (BMI), and the correlation between them after subtotal gastrectomy. METHODS: Forty-two patients with T0-1N0-1M0 gastric cancer were divided into two groups after gastrectomy according to digestive reconstruction pattern, Billroth Ⅰ group (n = 23) and Billroth Ⅱ group (n = 19). Ghrelin levels were determined with radioimmunoassay (RIA) before and on d 1, 7, 30 and 360 after gastrectomy, and BMI was also measured. RESULTS: The two groups had identical postoperative trends in ghrelin alterations during the early stage, both decreasing sharply to a nadir on d 1 (36.7% vs 35.7%), then markedly increasing on d 7 (51.0% vs 51.1%). On d 30, ghrelin levels in the Billroth Ⅰ group were slightly higher than those in the Billroth Ⅱ group. However, those of the Billroth Ⅰ group recovered to 93.6% on d 360, which approached, although lower than, the preoperative levels, and no statistically significant difference was observed. Those of the Billroth Ⅱ group recovered to only 81.6% and manifested significant discrepancy with preoperative levels (P = 0.033). Compared with preoperative levels, ghrelin levels of the two groups decreased by 6.9% and 18.4% and BMI fellby 3.3% and 6.4%, respectively. The linear regression correlations were revealed in both groups between decrease of ghrelin level and BMI (R12 = 0.297, P = 0.007; R22 = 0.559, P 〈 0.001).CONCLUSION: Anatomically and physiologically, the duodenum compensatively promotes ghrelin recovery and accordingly enhances BMI after gastrectomy. Regarding patients with insufficient ghrelin secretion, ghrelin is positively associated with BMI.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第15期2425-2429,共5页 世界胃肠病学杂志(英文版)
基金 The Research Foundation of Changzhou Health Bureau, No. WZ200708
关键词 DUODENUM GHRELIN Body mass index Subtotal gastrectomy Digestive reconstruction 消化系统 十二指肠 胃切除术 等离子调节
  • 相关文献

参考文献26

  • 1[1]Kojima M,Hosoda H,Date Y,Nakazato M,Matsuo H,Kangawa K.Ghrelin is a growth-hormone-releasing acylated peptide from stomach.Nature 1999; 402:656-660
  • 2[2]Date Y,Kojima M,Hosoda H,Sawaguchi A,Mondal MS,Suganuma T,Matsukura S,Kangawa K,Nakazato M.Ghrelin,a novel growth hormone-releasing acylated peptide,is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.Endocrinology 2000;141:4255-4261
  • 3[3]Van der Lely AJ,Tschop M,Heiman ML,Ghigo E.Biological,physiological,pathophysiological,and pharmacological aspects of ghrelin.Endocr Rev 2004; 25:426-457
  • 4[4]Hosoda H,Kojima M,Kangawa K.Biological,physiological,and pharmacological aspects of ghrelin.J Pharmacol Sci 2006;100:398-410
  • 5[5]Kojima M,Kangawa K.Drug insight:The functions of ghrelin and its potential as a multitherapeutic hormone.Nat Clin Pract Endocrinol Metab 2006; 2:80-88
  • 6[6]Davenport AP,Bonner TI,Foord SM,Harmar AJ,Neubig RR,Pin JP,Spedding M,Kojima M,Kangawa K.International Union of Pharmacology.LVI.Ghrelin receptor nomenclature,distribution,and function.Pharmacol Rev 2005; 57:541-546
  • 7[7]Kojima M,Kangawa K.Ghrelin:structure and function.Physiol Rev 2005; 85:495-522
  • 8[8]Tritos NA,Kokkotou EG.The physiology and potential clinical applications of ghrelin,a novel peptide hormone.Mayo Clin Proc 2006; 81:653-660
  • 9[9]Cummings DE.Ghrelin and the short-and long-term regulation of appetite and body weight.Physiol Behav 2006; 89:71-84
  • 10[10]Raybould HE.Visceral perception:sensory transduction in visceral afferents and nutrients.Gut 2002; 51 Suppl 1:i11-i14

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部